Summary
Oxford Biodynamics Plc (OBD) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Oxford Biodynamics Plc ever had a stock split?
Oxford Biodynamics Plc Profile
| Biotechnology Industry | Healthcare Sector | Iain Gladstone Ross CEO | LSE Exchange | - ISIN |
| GB Country | 51 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Oxford BioDynamics Plc is a pioneering biotechnology company that plays a crucial role in the discovery and development of biomarkers across a variety of medical and healthcare sectors, with a focus on serving the pharmaceutical and biotechnology industries. Founded in 2007 and based in Oxford, the United Kingdom, the company has made significant inroads into markets primarily in the United States and the United Kingdom. At the core of its operations is EpiSwitch, an innovative proprietary technology platform designed to revolutionize the screening, evaluation, validation, and ongoing monitoring of 3D genomic biomarkers. This technological advantage enables Oxford BioDynamics to offer advanced solutions for diagnosing patients with unprecedented precision.
Products and Services
- EpiSwitch Prostate Screening Test (PSE)
This pioneering product represents a significant advancement in prostate cancer screening. The EpiSwitch PSE is designed to improve early detection rates of prostate cancer, thereby potentially improving patient outcomes through early intervention.
- EpiSwitch CiRT (Checkpoint Inhibitor Response Test)
A ground-breaking blood test that predicts a patient's therapeutic response to checkpoint inhibitor immunotherapies. This test is crucial for personalizing cancer treatment plans, making sure patients receive the treatments most likely to be effective for their specific condition.
- EpiSwitch CST (Covid Severity Test)
An advanced blood test developed for predicting the severity of COVID-19 in adults. This tool is invaluable for medical professionals aiming to tailor treatment strategies based on the predicted severity of the infection in patients, potentially saving lives and optimizing healthcare resources during the pandemic.
- EpiSwitch Explorer Array Kit
Offers comprehensive high-resolution 3D genome profiling capabilities. This product is essential for researchers and clinicians who are involved in detailed genomic studies, providing them with the tools needed to explore and understand the complex nature of the genome in three dimensions.
